Agenus to Host First 2026 Stakeholder Webcast
Access to Acceleration: Agenus’ BOT+BAL Global Momentum Entering 2026 Webcast on Wednesday, January 28, 2026, at 4:00 p.m. ET LEXINGTON, Mass.–(BUSINESS... Read more.
H.C. Wainwright & Co. Is Once Again Ranked #1 by PlacementTracker
Number 1 Investment Bank for Confidentially Marketed Public Offerings, Registered Direct, Private Placement Offerings NEW YORK–(BUSINESS WIRE)–H.C. Wainwright... Read more.
Ventas Announces Tax Treatment of 2025 Distributions
CHICAGO–(BUSINESS WIRE)–Ventas, Inc. (NYSE: VTR) (the “Company”) announced today the tax treatment of its 2025 distributions on the Company’s common... Read more.
Puptqe Positions for National Growth in a $157 Billion U.S. Pet Market
TEMECULA, Calif.–(BUSINESS WIRE)–#Dogs–As more Americans treat their dogs as family and spend accordingly, Puptqe is expanding nationwide to bring... Read more.
TREX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Trex Company, Inc.
NEW YORK–(BUSINESS WIRE)–The law firm of Kirby McInerney LLP continues its investigation on behalf of Trex Company, Inc. (“Trex” or the “Company”)... Read more.
Nobilis Group Announces Executive Promotions, New COO
Stan Starnes Named President, Jeff Beaver as Chief Administrative Officer; Rushi Modha Hired as Chief Operating Officer IRVING, Texas–(BUSINESS WIRE)–Nobilis... Read more.
Oasis Submits Shareholder Proposals to Kobayashi Pharmaceutical for 2026 AGM
(Securities Code: 4967 JT) *Oasis urges Kobayashi Pharma shareholders to vote FOR a highly qualified, independent statutory auditor candidate *Oasis urges Kobayashi... Read more.
FRMI SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Fermi Inc. Investors – Contact Kirby McInerney LLP by March 6, 2026
NEW YORK–(BUSINESS WIRE)–Kirby McInerney LLP reminds investors who purchased Fermi Inc. (“Fermi” or the “Company”) (NASDAQ:FRMI) securities to... Read more.
PACS Group Announces the Acquisition of Three Post-Acute Operations and the Real Estate of Four Facilities
SALT LAKE CITY–(BUSINESS WIRE)–PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) today announced that independently operated subsidiaries... Read more.
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
Up to $100 million in additional loan proceeds provide additional financial flexibility to advance detalimogene development and commercialization for bladder cancer... Read more.